| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-64 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-64 |
| filingDate |
2002-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2fdb9e660a44fd88bf99904ba8d0644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e982508216a7b72404950fe4be975f69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97b9fcb593d0aa1933e6c1ab5e9fccaf |
| publicationDate |
2002-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002133015-A1 |
| titleOfInvention |
4-pyridinyl-N-acyl-L-phenylalanines |
| abstract |
Compounds of Formula I have activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4 and are useful for treating disease whose symptoms and or damage are related to the binding of VCAM-1 to cells expressing VLA-4. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8309735-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10562898-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005192279-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005209232-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102008002276-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015031715-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009203745-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9447035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6960597-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002091115-A1 |
| priorityDate |
1999-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |